Fibrogen Announces $50 Million Royalty Monetization Financing With Novaquest Capital Management
Amount Raised
$50 Million
Round Type
Funding Round
San FranciscoBiotechnologyTherapeuticsBiopharmaDescription
FibroGen, Inc. (NASDAQ: FGEN) today announced a royalty monetization financing with NovaQuest Capital Management (NovaQuest) that will result in proceeds to FibroGen in the amount of $50 million, bringing non-dilutive capital to drive innovation and growth.
Quick answer
FibroGen raised $50 Million in a Funding Round round, dated November 7, 2022. FibroGen is based in San Francisco, California, United States.
- How much did FibroGen raise?
- FibroGen raised $50 Million in a Funding Round round on November 7, 2022.
- What does FibroGen do?
- FibroGen, Inc. is a biopharmaceutical company focused on accelerating the development of novel therapies at the frontiers of cancer biology.
- Where is FibroGen based and how big is it?
- FibroGen is based in San Francisco, California, United States.
- Who are the decision-makers at FibroGen?
- Fundz holds 4 contacts at FibroGen, including the Head of Translational Medicine, Sr. Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as FibroGen that raised within 45 days of this round, from Fundz verified event records.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Biomica raised $20M (Funding Round) on December 21, 2022.
- Alpha-9 Theranostics raised $75M (Series B) on December 14, 2022.
- Entero Therapeutics raised $2.5M (Seed) on November 22, 2022.
- Opna Bio raised $38M (Series A) on November 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
Who to call at FibroGen, and when
A new round usually means FibroGen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day FibroGen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at FibroGen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at FibroGen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment FibroGen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
FibroGen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.